QuadMedicine Statistics

Total Valuation

QuadMedicine has a market cap or net worth of KRW 162.98 billion. The enterprise value is 166.07 billion.

Market Cap	162.98B
Enterprise Value	166.07B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

QuadMedicine has 11.34 million shares outstanding. The number of shares has increased by 6.13% in one year.

Current Share Class	11.34M
Shares Outstanding	11.34M
Shares Change (YoY)	+6.13%
Shares Change (QoQ)	+2.49%
Owned by Insiders (%)	25.69%
Owned by Institutions (%)	0.01%
Float	7.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	12.43
PB Ratio	25.44
P/TBV Ratio	27.51
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-30.28
EV / Sales	12.67
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-22.01

Financial Position

The company has a current ratio of 1.47, with a Debt / Equity ratio of 1.15.

Current Ratio	1.47
Quick Ratio	1.35
Debt / Equity	1.15
Debt / EBITDA	n/a
Debt / FCF	-0.97
Interest Coverage	-13.53

Financial Efficiency

Return on equity (ROE) is -110.51% and return on invested capital (ROIC) is -25.11%.

Return on Equity (ROE)	-110.51%
Return on Assets (ROA)	-11.81%
Return on Invested Capital (ROIC)	-25.11%
Return on Capital Employed (ROCE)	-22.52%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.50
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	46.36
Average Volume (20 Days)	798,553

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, QuadMedicine had revenue of KRW 13.11 billion and -5.49 billion in losses. Loss per share was -592.68.

Revenue	13.11B
Gross Profit	13.11B
Operating Income	-4.97B
Pretax Income	-5.49B
Net Income	-5.49B
EBITDA	-1.65B
EBIT	-4.97B
Loss Per Share	-592.68

Full Income Statement

Balance Sheet

The company has 4.25 billion in cash and 7.35 billion in debt, with a net cash position of -3.10 billion or -273.16 per share.

Cash & Cash Equivalents	4.25B
Total Debt	7.35B
Net Cash	-3.10B
Net Cash Per Share	-273.16
Equity (Book Value)	6.41B
Book Value Per Share	668.08
Working Capital	2.03B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -5.65 billion and capital expenditures -1.89 billion, giving a free cash flow of -7.54 billion.

Operating Cash Flow	-5.65B
Capital Expenditures	-1.89B
Free Cash Flow	-7.54B
FCF Per Share	-665.17

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -37.88% and -41.84%.

Gross Margin	100.00%
Operating Margin	-37.88%
Pretax Margin	-41.84%
Profit Margin	-41.84%
EBITDA Margin	-12.61%
EBIT Margin	-37.88%
FCF Margin	n/a

Dividends & Yields

QuadMedicine does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.13%
Shareholder Yield	-6.13%
Earnings Yield	-3.37%
FCF Yield	-4.63%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

QuadMedicine has an Altman Z-Score of -2.59 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.59
Piotroski F-Score	2